about
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery te...
Read More
2.08
-0.03
(-1.42%)
2,438.8
XNAS Volume
XNAS 18 Mar, 2026 1:32 PM (EDT)
Board Meeting
The next board meeting for Pulmatrix Inc is on 20 Mar 2026 for the purpose of Pulmatrix Inc Annual Report for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Pulmatrix Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..